The optometrist’s role in inherited retinal diseases
Historically, patients with rare inherited retinal diseases (IRDs) were told there was no treatment to stop them from losing their vision. But this is changing. In 2017, the world’s first ocular gene therapy treatment, Luxturna (voretigene neparvovec-rzyl), was approved by the US Food and Drug Admin
5 min read
